A pilot study of sertraline for depression in age-related macular degeneration [5]

American Journal of Geriatric Psychiatry

Volumn 14, Issue 8, 2006, Pages 718-719

  Rovner, Barry W ^a   Pasternak, Rona ^a   Casten, Robin ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGED; CLINICAL ARTICLE; COGNITION; DEPRESSION; DIARRHEA; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; LETTER; MALE; NAUSEA; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; VISUAL ACUITY;

EID: 33746878857     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.JGP.0000214494.93087.7c     Document Type: Letter

References (5)

1. Rovner BW, Gasten R, Tasman W: Depression impairs self-reported vision function in age-related macular degeneration. Arch Ophthalmol 2002; 10:305-310
2. Massof RW, Fletcher DC: Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Res 2001; 41:397-413
3. Schneider LS, Nelson JC, Clary CM, et al: An 8-week multi-center parallel-group, double-blind placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 2003; 160:1277-1285
4. Mottran PG, Wilson KCM, Ashworth L, et al: The clinical profile of older patients' response to antidepressants-an open trial of sertraline. Int J Geriatr Psychiatry 2002; 17:574-578
5. Dalton SO, Johansen C, Nellemkjaer L, et al: Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding. Arch Intern Med 2003;163:59-64